Alcami St. Louis Facility to be Honored by Missouri House of Representatives and City of St. Louis

DURHAM, N.C., May 3, 2018 /PRNewswire/ — Alcami Corporation, a leading provider of fully-integrated custom end-to-end solutions for the pharmaceutical and biotechnology industries, today announces the Missouri House of Representatives and St. Louis Mayor Lyda Krewson will honor Alcami with a resolution and letter of recommendation, recognizing the company's operational excellence, celebrating its industry-leading accomplishments, and applauding the organization for improving St. Louis citizens' quality of life.

State Representative Steven Roberts of St. Louis District 77 and City of St. Louis Chief Technology Officer Robert Gaskill-Clemons will issue the proclamation and congratulatory letter Tuesday, May 8, 20182:00 p.m., at an invitation-only customer open house event inside Alcami's state-of-the-art Center of Excellence for analytical testing. The new facility, located at 4260 Forest Park Avenue, Suite 201, St. Louis, Missouri 63108, was engineered for operational excellence and is the gem of the Cortex Innovation Community, the Midwest's leading center for bioscience and technology research, development and commercialization.

Alcami's St. Louis Center of Excellence provides analytical testing services for manufacturers' new drug entities, generics, animal health products, active pharmaceutical ingredients, raw materials, in-process goods, medicated consumer health products, chemicals, biologics, and biopharmaceuticals. The company uses a wide variety of techniques to identify the chemical makeup of a sample, which help ensure the drugs Alcami's customers have developed are safe and effective for patients around the world.

Alcami is committed to strengthening partnerships within local communities, with a Foundations team comprised of cross-functional contributors that assess and make decisions about community outreach activities, academic partnerships, charitable and nonprofit opportunities, sponsorships, and memberships. The Foundations team supports St. Louis organizations that advance the health industry, as well as science, technology, engineering, arts, and mathematics (STEAM); economic; environmental; and various other social initiatives in alignment with the company's mission and values.

SOURCE Alcami Corporation

 

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Alcami

Alcami is a world-class CDMO specializing in API development and manufacturing, solid state chemistry, formulation development, analytical development and testing services, clinical and commercial finished dosage form manufacturing, packaging and stability services. Based in North Carolina with seven sites throughout the US and Europe, Alcami employs an integrated approach to drug development, offering end-to-end services for increased efficiency from discovery through commercialization. Alcami is the first company to offer a solution tailored specifically to small and mid-sized pharmaceutical and biotech companies, providing customers with a simplified engagement that includes a single project management relationship, full visibility from development into manufacturing and shorter turnaround times.

Q: